Showing results (91-100 of 155) with videos related to

Sort By:
Pageof 16
International Journal of Environmental Research and Public Health|October 13, 2021
Combination of Modified Scarf Osteotomy and Metatarsal Shortening Offset Osteotomy for Rheumatoid Forefoot DeformityYuki Etani, Makoto Hirao, Kosuke Ebina, et al.
Modern Rheumatology|June 9, 2018
The add-on effectiveness and safety of iguratimod in patients with rheumatoid arthritis who showed an inadequate response to tocilizumabKosuke Ebina, Akira Miyama, Hideki Tsuboi, et al.
Biochemical and Biophysical Research Communications|August 23, 2015
Progranulin plays crucial roles in preserving bone mass by inhibiting TNF-α-induced osteoclastogenesis and promoting osteoblastic differentiation in miceTakaaki Noguchi, Kosuke Ebina, Makoto Hirao, et al.
Modern Rheumatology|January 25, 2019
Impact of combining medial capsule interposition with modified scarf osteotomy for hallux valgusKosuke Ebina, Makoto Hirao, Hideki Tsuboi, et al.
Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association|June 1, 2023
Early mobilization of dorsiflexion from 3 days after cemented total ankle arthroplasty with modified antero-lateral approachYusei Higuchi, Makoto Hirao, Takaaki Noguchi, et al.
The Journal of Bone and Joint Surgery. American Volume|June 14, 2022
Modified Scarf Osteotomy with Medial Capsular Interposition Combined with Metatarsal Shortening Offset Osteotomy: A Comparison of Patients with Noninflammatory Arthritis and Rheumatoid Arthritis of the FootYuki Etani, Makoto Hirao, Kosuke Ebina, et al.
Clinical Rheumatology|December 17, 2008
Serum adiponectin concentrations correlate with severity of rheumatoid arthritis evaluated by extent of joint destructionKosuke Ebina, Atsunori Fukuhara, Wataru Ando, et al.
Bone|February 7, 2024
Iguratimod suppresses sclerostin and receptor activator of NF-κB ligand production via the extracellular signal-regulated kinase/early growth response protein 1/tumor necrosis factor alpha pathway in osteocytes and ameliorates disuse osteoporosis in miceTaihei Miura, Yuki Etani, Takaaki Noguchi, et al.
Modern Rheumatology|May 16, 2020
Effects of follow-on therapy after denosumab discontinuation in patients with postmenopausal osteoporosisKosuke Ebina, Jun Hashimoto, Masafumi Kashii, et al.
Scientific Reports|October 27, 2022
A novel anti-TNF-α drug ozoralizumab rapidly distributes to inflamed joint tissues in a mouse model of collagen induced arthritisShohei Oyama, Kosuke Ebina, Yuki Etani, et al.
Pageof 16